Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Interactions of doctors with the pharmaceutical industry
- Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review
- Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
- Medical students’ exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France
- Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study
- Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform
- Conflict of interest among Italian medical oncologists: a national survey
- General practitioners and pharmaceutical sales representatives: quality improvement research
- Ethical issues raised by the introduction of payment for performance in France
- Biomedical conflicts of interest: a defence of the sequestration thesis—learning from the cases of Nancy Olivieri and David Healy